GAMMA Investing’s Invesco Pharmaceuticals ETF PJP Stock Holding History

GAMMA Investing’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.5K	Hold	241	–	–	﹤0.01%	2649
2026 Q1	$25K	Sell	241 -187	-44%	-$19.8K	﹤0.01%	2608
2025 Q4	$44.7K	Hold	428	–	–	﹤0.01%	2134
2025 Q3	$39.6K	Hold	428	–	–	﹤0.01%	2146
2025 Q2	$34.2K	Hold	428	–	–	﹤0.01%	2162
2025 Q1	$37.1K	Sell	428 -63	-13%	-$5.37K	﹤0.01%	2004
2024 Q4	$40.6K	Hold	491	–	–	﹤0.01%	1819
2024 Q3	$42.7K	Hold	491	–	–	﹤0.01%	1604
2024 Q2	$40.4K	Buy	+491	New	+$39K	0.01%	1349

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

GAMMA Investing's PJP Position: Q2 2026 in Review

GAMMA Investing held its Invesco Pharmaceuticals ETF (PJP) position steady in Q2 2026 at 241 shares worth $28.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2649.

GAMMA Investing first reported a position in PJP in Q2 2024 and has held it in 9 quarters since. The position peaked at $44.7K in Q4 2025. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

GAMMA Investing held 241 shares of Invesco Pharmaceuticals ETF worth $28.5K as of Q2 2026.
GAMMA Investing left its Invesco Pharmaceuticals ETF share count unchanged in Q2 2026.
Invesco Pharmaceuticals ETF made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2649 holding.
GAMMA Investing first reported a position in Invesco Pharmaceuticals ETF in Q2 2024 and has held it in 9 quarters since.
GAMMA Investing's Invesco Pharmaceuticals ETF position peaked at $44.7K in Q4 2025.
117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.